<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03107104</url>
  </required_header>
  <id_info>
    <org_study_id>Triton FA FAF</org_study_id>
    <nct_id>NCT03107104</nct_id>
  </id_info>
  <brief_title>Triton Fundus Autofluorescence and Fluorescein Angiography</brief_title>
  <official_title>Topcon DRI OCT Triton (Plus) Fundus Autofluorescence and Fluorescein Angiography Image Quality Evaluation Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Topcon Medical Systems, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Topcon Medical Systems, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Compare the image quality of the fundus autofluorescence and fluorescein angiography
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objectives of this study are to:

        1. Compare the image quality of the fundus autofluorescence (FAF) photographs between DRI
           OCT Triton (plus) and TRC-50DX retinal camera.

        2. Compare the image quality of the fluorescein angiography (FA) photographs between DRI
           OCT Triton (plus) and TRC-50DX retinal camera.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 30, 2017</start_date>
  <completion_date type="Anticipated">September 30, 2017</completion_date>
  <primary_completion_date type="Anticipated">August 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fundus autofluorescence image quality</measure>
    <time_frame>1 Minute</time_frame>
    <description>Comparison of DRI OCT Triton (plus) and TRC-50DX photographs</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fluorescein angiography image quality at 120 seconds to 300 seconds after dye injection</measure>
    <time_frame>120 seconds to 300 seconds</time_frame>
    <description>Comparison of DRI OCT Triton (plus) and TRC-50DX photographs</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fluorescein angiography image quality at greater than 300 seconds after dye injection</measure>
    <time_frame>greater than 300 seconds</time_frame>
    <description>Comparison of DRI OCT Triton (plus) and TRC-50DX photographs</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Medical Need for Fluorescein Angiography Imaging</condition>
  <arm_group>
    <arm_group_label>Medical need for FA imaging</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects deemed to have a medical need for FA imaging will be imaged on the Topcon DRI OCT Triton (plus) and TRC-50DX retinal camera</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Topcon DRI OCT Triton (plus)</intervention_name>
    <description>The Topcon DRI OCT Triton (plus) is an OCT with a fundus camera used for diagnostic purposes</description>
    <arm_group_label>Medical need for FA imaging</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TRC-50DX retinal camera</intervention_name>
    <description>The TRC-50DX retinal camera is a fundus camera used for diagnostic purposes</description>
    <arm_group_label>Medical need for FA imaging</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          1. Subjects must be at least 18 years of age

          2. Subjects able to understand the written informed consent and willing to participate as
             evidenced by signing the informed consent

          3. Subjects who consent to, via clinic's standard FA consent form, and will undergo dye
             injection for FA imaging at the clinic visit based on medical need

        Exclusion Criteria

          1. Subjects unable to tolerate ophthalmic imaging

          2. Subjects with ocular media not sufficiently clear to obtain acceptable fundus images

          3. Patients with ocular motility dysfunction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Charles Riesman, MS</last_name>
    <role>Study Chair</role>
    <affiliation>Topcon Corporation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vitreous Retina Macula Consultants of New York</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10022</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2017</study_first_submitted>
  <study_first_submitted_qc>April 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 11, 2017</study_first_posted>
  <last_update_submitted>August 3, 2017</last_update_submitted>
  <last_update_submitted_qc>August 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

